Latest / The Onco Life Podcast
Personalized Cancer Vaccine Shows Long-Term Promise for High-Risk Melanoma Patients
In this episode, we explore promising new research on a personalized cancer vaccine that may help reduce cancer recurrence and improve long-term survival for patients with high-risk melanoma.You’ll learn:• What a personalized cancer vaccine is and how mRNA technology is being used in cancer treatment• Key findings from the Phase 2b KEYNOTE-942 melanoma trial• How the vaccine reduced the risk of distant cancer spread by 59% and recurrence or death by 49%• Why combining a personalized vaccine with an immune checkpoint inhibitor may improve outcomes• How tumor-specific neoantigens help train the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.